These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7798888)

  • 1. RB tumor suppressor gene expression in hepatocellular carcinomas from patients infected with the hepatitis B virus.
    Hsia CC; Di Bisceglie AM; Kleiner DE; Farshid M; Tabor E
    J Med Virol; 1994 Sep; 44(1):67-73. PubMed ID: 7798888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet.
    Hsia CC; Kleiner DE; Axiotis CA; Di Bisceglie A; Nomura AM; Stemmermann GN; Tabor E
    J Natl Cancer Inst; 1992 Nov; 84(21):1638-41. PubMed ID: 1279184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-alpha in human hepatocellular carcinoma and coexpression with hepatitis B surface antigen in adjacent liver.
    Hsia CC; Axiotis CA; Di Bisceglie AM; Tabor E
    Cancer; 1992 Sep; 70(5):1049-56. PubMed ID: 1325266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue microarray immunohistochemical profiles of p53 and pRB in hepatocellular carcinoma and hepatoblastoma.
    Azlin AH; Looi LM; Cheah PL
    Asian Pac J Cancer Prev; 2014; 15(9):3959-63. PubMed ID: 24935581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the G1-S modulators in hepatitis B virus-related hepatocellular carcinoma and dysplastic nodule: association of cyclin D1 and p53 proteins with the progression of hepatocellular carcinoma.
    Choi YL; Park SH; Jang JJ; Park CK
    J Korean Med Sci; 2001 Aug; 16(4):424-32. PubMed ID: 11511787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma.
    Shieh YS; Nguyen C; Vocal MV; Chu HW
    Int J Cancer; 1993 Jun; 54(4):558-62. PubMed ID: 8390407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical p53 in hepatocellular carcinoma and liver cell dysplasia.
    Cohen C; DeRose PB
    Mod Pathol; 1994 Jun; 7(5):536-9. PubMed ID: 7937718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
    Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
    Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron, ferritin, hepatitis B surface and core antigens in the livers of Chinese patients with hepatocellular carcinoma.
    Zhou XD; DeTolla L; Custer RP; London WT
    Cancer; 1987 Apr; 59(8):1430-7. PubMed ID: 3028601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the retinoblastoma gene product in human hepatocellular carcinoma.
    Seki S; Kawakita N; Yanai A; Kitada T; Sakai Y; Nakatani K; Yamada T; Sakaguchi H; Kuroki T
    Hum Pathol; 1995 Apr; 26(4):366-74. PubMed ID: 7535739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 expression in hepatocellular carcinoma in a population in Singapore with endemic hepatitis B virus infection.
    Wee A; Teh M; Raju GC
    J Clin Pathol; 1995 Mar; 48(3):236-8. PubMed ID: 7730484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India.
    Katiyar S; Dash BC; Thakur V; Guptan RC; Sarin SK; Das BC
    Cancer; 2000 Apr; 88(7):1565-73. PubMed ID: 10738214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain metastasis from hepatocellular carcinoma associated with hepatitis B virus.
    Frati A; Salvati M; Giarnieri E; Santoro A; Rocchi G; Frati L
    J Exp Clin Cancer Res; 2002 Sep; 21(3):321-7. PubMed ID: 12385572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The expression of p16, CDK4 and pRb in hepatocellular carcinomas].
    Luo D; Liu Q; Su J
    Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):94-5. PubMed ID: 10488417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood hepatocellular carcinoma develops exclusively in hepatitis B surface antigen carriers in three decades in Taiwan. Report of 51 cases strongly associated with rapid development of liver cirrhosis.
    Hsu HC; Wu MZ; Chang MH; Su IJ; Chen DS
    J Hepatol; 1987 Dec; 5(3):260-7. PubMed ID: 2828461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of mutant p53 in chronic HBV infection and hepatocellular carcinoma].
    Chen Y; Tang ZY; Li J
    Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):184-7. PubMed ID: 7956695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of hepatitis B surface and core antigens in human liver cell carcinoma and surrounding nontumorous liver.
    Hirohashi S; Shimosato Y; Ino Y; Kishi K
    J Natl Cancer Inst; 1982 Sep; 69(3):565-8. PubMed ID: 6287080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of transforming growth factor-alpha in hepatocellular carcinoma and focal nodular hyperplasia from European patients.
    Schaff Z; Hsia CC; Sarosi I; Tabor E
    Hum Pathol; 1994 Jul; 25(7):644-51. PubMed ID: 8026823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 expression in patients with cirrhosis with and without hepatocellular carcinoma.
    Livni N; Eid A; Ilan Y; Rivkind A; Rosenmann E; Blendis LM; Shouval D; Galun E
    Cancer; 1995 May; 75(10):2420-6. PubMed ID: 7736384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.